Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,074 | -23,475 | -21,396 | -10,438 | -34,657 |
| Depreciation Amortization | 2,370 | 1,837 | 1,427 | 823 | 3,184 |
| Income taxes - deferred | 33,337 | 32,798 | -199 | -178 | -1,702 |
| Accounts payable and accrued liabilities | -2,713 | -352 | 321 | 95 | -497 |
| Other Working Capital | 14,802 | 12,567 | 9,580 | -590 | -222 |
| Other Operating Activity | -39,791 | -49,282 | 2,715 | 1,441 | 5,130 |
| Operating Cash Flow | $-42,069 | $-25,907 | $-7,552 | $-8,847 | $-28,764 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,707 | -1,950 | -500 | -343 | -591 |
| Net Acquisitions | 27,759 | 27,759 | N/A | N/A | N/A |
| Purchase Of Investment | -11,500 | -11,500 | -11,500 | -1,500 | -10,000 |
| Investing Cash Flow | $12,552 | $14,309 | $-12,000 | $-1,843 | $-10,591 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -3,095 | N/A | N/A | N/A | 7,500 |
| Debt Repayment | N/A | -1,915 | -758 | N/A | N/A |
| Common Stock Issued | 1,699 | 1,678 | 1,107 | 289 | 72,090 |
| Other Financing Activity | -1,951 | -1,000 | -1,000 | -1,000 | 0 |
| Financing Cash Flow | $-3,347 | $-1,237 | $-651 | $-711 | $79,590 |
| Beginning Cash Position | 71,902 | 71,902 | 71,902 | 71,902 | 31,667 |
| End Cash Position | 39,038 | 59,067 | 51,699 | 60,501 | 71,902 |
| Net Cash Flow | $-32,864 | $-12,835 | $-20,203 | $-11,401 | $40,235 |
| Free Cash Flow | |||||
| Operating Cash Flow | -42,069 | -25,907 | -7,552 | -8,847 | -28,764 |
| Capital Expenditure | -3,707 | -1,950 | -500 | -343 | -591 |
| Free Cash Flow | -45,776 | -27,857 | -8,052 | -9,190 | -29,355 |